HALO logo
halo search icon
PYC
PYC Therapeutics Limited

PYC · PYC Therapeutics Limited

2.75

AUD
-0.07 (-2.482%)
28/09/2026 04:10:26 PM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$2.86B

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 28/09/2026 04:10:26 PM

Price Chart

Description

PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001, and is headquartered in Nedlands, Australia.

  • All-Companies
  • All-Consensus
  • GROWTH AUS
  • HALO Earnings Momentum
  • HALO Momentum
  • HALO Ords
  • HALO Price Momentum
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-13.10%

EBITDA Margin

N/A

Operating Cashflow

-$45m

Free Cash Flow Return

-10.30%

ROIC

-10.00%

Interest Coverage

NaN

Quick Ratio

33.50

Performance

52 weeks range

Low 0.97 - 2.93

Trade Value (12mth)

AU$807,241.00

1 week

5.62%

1 month

25.33%

YTD

74.48%

1 year

180.36%

All time high

6.31

Additional Data

Shares Outstanding (Fully Diluted)

984m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

1.04

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
11 September 26ASXD
26 August 26ASXD
18 August 26ASXD
14 August 26ASXD
13 August 26ASXD

Key Stakeholders

NameTitle
Australia Land Pty Ltd.Private Company
Retail Employees Superannuation Pty Ltd.Private Company
McCusker Holdings Pty Ltd.Private Company
Trexon Pty Ltd.Private Company
Metcash Ltd.Public Company

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of PYC Therapeutics Limited (PYC:ASX)?
Halo FAQ
The current share price of PYC Therapeutics Limited (PYC:ASX) is AUD$2.75.
2
What is the 52-week high share price for PYC Therapeutics Limited (PYC:ASX)?
Halo FAQ
The 52-week high share price for PYC Therapeutics Limited (PYC:ASX) is AUD$2.93.
3
What is the 52-week low share price for PYC Therapeutics Limited (PYC:ASX)?
Halo FAQ
The 52-week low share price for PYC Therapeutics Limited (PYC:ASX) is AUD$0.97.
4
What is the dividend yield for PYC Therapeutics Limited (PYC:ASX)?
Halo FAQ
PYC Therapeutics Limited (PYC:ASX) does not pay a dividend.
5
What was PYC Therapeutics Limited (PYC:ASX) last dividend payment?
Halo FAQ
PYC Therapeutics Limited (PYC:ASX) does not pay a dividend.
6
What is the franking level for PYC Therapeutics Limited (PYC:ASX)?
Halo FAQ
PYC Therapeutics Limited (PYC:ASX) has a franking level of 0.00%.
7
In which sector is PYC Therapeutics Limited (PYC:ASX) classified?
Halo FAQ
PYC Therapeutics Limited (PYC:ASX) is classified in the Healthcare.